MOTS-C 20mg Peptide – Lyophilized Powder for Laboratory Research

Product Overview

Global Peptides Lab presents MOTS-C 20mg, a lyophilized peptide supplied in powder form for laboratory research applications. This product is intended for qualified research environments where peptide materials may be examined under appropriate laboratory conditions. It is supplied as a dry powder and has not been reconstituted.

MOTS-c is a mitochondria-associated peptide that has attracted scientific interest because of its relationship to cellular energy regulation and metabolic research. Researchers studying mitochondrial biology and cellular signalling may encounter MOTS-c in the scientific literature. However, ongoing scientific interest does not establish that an investigational peptide is safe or effective for human use.

At Global Peptides Lab, clear product information and transparent reporting of available batch test results are important parts of the purchasing process. This listing provides the available specifications, reported analytical results, and essential information about the supplied material.

What Is MOTS-C?

MOTS-c is a short peptide encoded by a region of mitochondrial DNA. It has been investigated in experimental research examining mitochondrial communication, cellular stress responses, and metabolic signalling pathways.

Mitochondria are structures within cells that play important roles in energy production and other cellular processes. Scientists study how mitochondrial signals interact with the nucleus and other cellular systems to understand complex biological mechanisms.

Research involving MOTS-c remains an evolving field. Findings from laboratory experiments do not automatically demonstrate clinical benefits, and further investigation is necessary to establish the relevance of experimental findings to human health.

For researchers exploring this area, MOTS-c provides a subject for controlled laboratory investigation. It should not be confused with an approved medicine or an established treatment.

MOTS-C 20mg Product Specifications

The product is supplied in a sealed vial containing lyophilized powder. Lyophilization is a drying process used to remove water from a material under controlled conditions. It is commonly used for certain laboratory reagents and research materials.

The available product specifications are listed below.

• Product name: MOTS-C 20mg
• Product category: Research peptide
• Form: Lyophilized powder
• Vial type: Glass vial
• Vial size: 7 mL (6R)
• Reconstitution status: Not reconstituted
• Reported purity: 98.672%
• Reported sample weight: 23.77 mg
• TFA test: Not detected
• Sterility test: Pass
• Endotoxins (LPS): Pass
• Batch number: MO05261320L
• Date tested: June 5, 2026

These specifications reflect the information provided for the identified batch. Actual product characteristics and test interpretations should be confirmed against the original laboratory report.

Important batch clarification: The listed product strength is 20mg, while the supplied test information reports a measured weight of 23.77mg. Total sample weight and the amount of the intended peptide are not necessarily equivalent. Global Peptides Lab should verify this discrepancy against the original certificate of analysis and confirm the correct labelled peptide content before publication or sale.

MOTS-C Peptide Purity and Laboratory Testing

Analytical testing can help researchers assess important characteristics of laboratory materials. For this batch, the supplied results include purity, measured weight, trifluoroacetic acid (TFA), sterility, and endotoxin testing.

Reported purity: 98.672%

The supplied batch results report a purity value of 98.672%. Purity measurements describe the proportion attributed to the target material under a particular analytical method. The meaning and limitations of a reported value depend on the method used, the reference standard, and the laboratory’s reporting criteria.

A purity percentage alone does not establish identity, potency, biological activity, or suitability for a particular experiment. Researchers should consult the underlying analytical documentation when these characteristics are important to their work.

TFA testing: Not detected

The provided report lists the TFA test result as not detected. TFA, or trifluoroacetic acid, may be associated with certain peptide manufacturing and purification processes. A not-detected result means the substance was not detected under the conditions and reporting limits of the stated test; it does not necessarily mean absolute zero.

Sterility: Pass

The supplied report records a passing sterility result. Sterility testing is intended to assess microbial contamination according to the method and acceptance criteria used. The scope of a passing result depends on the sample, testing procedure, and laboratory documentation.

Endotoxins (LPS): Pass

The batch information also records a passing result for endotoxins, including lipopolysaccharides (LPS). Endotoxins are components associated with the outer membrane of certain bacteria. Their assessment is relevant in laboratory settings where contamination could affect experimental results.

A reported pass should be interpreted in the context of the test method, detection limit, and applicable acceptance criteria.

Sample weight: 23.77 mg

The supplied results state a sample weight of 23.77 mg. This value requires clarification alongside the nominal 20mg product label to establish whether it refers to gross material weight, net powder weight, or another reported measurement. Buyers should rely on a verified batch report for the exact quantity and composition.

Why Clear Batch Information Matters

When evaluating research peptides, researchers need more than a product name and an attractive listing. Relevant documentation can help them determine whether a material is appropriate for their intended laboratory work.

Global Peptides Lab aims to provide clearly presented product information, including the physical form, vial specifications, batch identification, and available analytical results.

For MOTS-C 20mg, the supplied batch information provides several useful starting points for reviewing the material. Nevertheless, test results should not be interpreted beyond the scope of the actual methods used. Independent verification, where appropriate, can provide additional confidence in identity, content, and other characteristics relevant to a research protocol.

Storage and Handling Information

Follow the storage and handling conditions stated by the manufacturer and the accompanying product documentation. Appropriate conditions can vary depending on the formulation, packaging, and stability data available for a particular batch.

Keep the vial in its original packaging when appropriate, protect the material from conditions that could compromise its stability, and follow the laboratory’s established procedures for handling research chemicals and biological materials.

Do not assume a specific storage temperature, shelf life, or post-reconstitution stability period without supporting documentation. This product is supplied as a lyophilized powder and has not been reconstituted. Any preparation or handling should be performed only by qualified personnel following validated procedures and relevant safety requirements.

Research Use and Important Limitations

MOTS-c is an investigational peptide, and research findings should be interpreted cautiously. This product listing does not establish that the material is approved for human or veterinary use, nor does it support claims that it treats disease, causes weight loss, improves athletic performance, or prevents ageing.

The material is intended for appropriate laboratory research use only, subject to applicable laws and institutional requirements. It is not presented as a dietary supplement, approved medicine, or product for self-administration.

Researchers should review available documentation, assess material suitability for their specific work, and follow all relevant laboratory safety procedures.

Frequently Asked Questions

1. What is MOTS-C 20mg?

MOTS-C 20mg is a lyophilized peptide product supplied in vial form for laboratory research purposes. The product is listed as dry powder and has not been reconstituted.

2. What is the reported purity of this batch?

The supplied test results dated June 5, 2026, report a purity of 98.672%. The original laboratory report should be consulted to confirm the analytical method and its limitations.

3. Has the product undergone sterility and endotoxin testing?

The supplied batch information lists sterility as Pass and endotoxins (LPS) as Pass. These results should be interpreted according to the original laboratory report and its acceptance criteria.

4. What does the TFA result mean?

The supplied report states that TFA was not detected. This indicates that TFA was not detected under the test conditions and reporting limits; it does not establish absolute absence.

5. Is the product supplied as a liquid?

No. The supplied product specification identifies the material as lyophilized powder in a 7 mL vial. It has not been reconstituted.

6. Is MOTS-c approved for human use?

This listing does not present MOTS-c as an approved medicine. Investigational research findings should not be treated as proof of safety or efficacy in humans.

7. Where can I find the batch information?

The supplied batch number is MO05261320L, with a reported test date of June 5, 2026. Refer to the corresponding original test report for details and verification.

Final Product Information

Global Peptides Lab provides this listing to communicate the product’s stated specifications and available batch-testing information. Before purchasing, researchers should review the documentation relevant to their work and confirm any details that affect product identity, quantity, or suitability.

Transparent specifications, appropriately interpreted analytical results, and responsible research practices are essential when evaluating laboratory peptide materials.